A new study reveals that acetaminophen use and over-dosing rise in cold/flu season in the United States, primarily due to increased use of over-the-counter combination medications treating upper respiratory symptoms. Another study reports that acetaminophen is the most commonly used analgesic in France, with more high-dose tablets being consumed in recent years. The findings, which are published in the British Journal of Clinical Pharmacology, indicate that individuals should take special care to follow labeled dosing directions for acetaminophen-containing products.
Chances are you or someone you know has used nonsteroidal anti-inflammatory drugs (NSAIDs) within the last month. NSAIDs, such as Advil (ibuprofen), Aleve (naproxen) and Celebrex, are among the most commonly used medicines in the US. Now, for the first time, researchers have found that 15 percent of adult ibuprofen users exceed the maximum recommended dose of ibuprofen or other NSAIDs in a one-week period.
Black women are among those most likely to have insomnia, according to Lynn Rosenberg, ScD, associate director of Boston University’s Slone Epidemiology Center and a principal investigator of the Black Women’s Health Study (BWHS). Rosenberg has been awarded a three-year $2,225,495 grant from the Patient-Centered Outcomes Research Institute (PCORI) to study this. The study will be using a self-administered internet program called SHUTi (Sleep Healthy Using the Internet), a web-tool based on cognitive behavioral therapy (CBT).
Among African-American women, those with type 2 diabetes may have a higher risk of developing estrogen receptor (ER)-negative breast cancer.
The rate of pregnant women receiving a tetanus, diphtheria and pertussis vaccine jumped dramatically in numerous metropolitan areas of the United States — by more than 50% over several years — according to the CDC. The increase in immunization stems from recommendations from the Advisory Committee on Immunization Practices, researchers said.
Dr. Julie Palmer awarded AACR Distinguished Lecture on the Science of Cancer Health Disparities, funded by Susan G. Komen®
This award honors an investigator whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment or prevention of cancer health disparities.
Too many black women die from breast cancer. Why? BU Slone Epidemiology Center researchers look for answers
Breast cancer is not color-blind. Although it strikes women (and less commonly, men) of every age and race, black women are more likely than white women to die of breast cancer. Why?
Black women under the age of 45 are at increased risk for an aggressive form of breast cancer [estrogen receptor (ER) negative] if they experienced a high number of pregnancies, never breast fed, and/or had higher waist-to-hip ratio.
Why do African American women die at higher rates from breast cancer and experience more aggressive breast tumors than white women?
School of Public Health researchers affiliated with the Slone Epidemiology Center (SEC) have received funding from the National Cancer Institute (NCI) to explore this question. The new grant is based on the premise that having a better understanding of the biology of breast cancer in African American women will lead to better prevention and treatment.
Why do African-American women die at a higher rate and experience more aggressive breast tumors than white women? Researchers from Boston University’s Slone Epidemiology Center (SEC) have received funding from the National Cancer Institute (NCI) to explore this question. The new grant is based on the premise that having a better understanding of the biology of breast cancer in African-American women will lead to better prevention and treatment.